ArticleVaccine2021

One or two dose regimen of the SARS-CoV-2 synthetic DNA vaccine INO-4800 protects against respiratory tract disease burden in nonhuman primate challenge model.

Karen E Gooch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.